Featured Stories
PALTmed Welcomes CMS Proposal to Restore Payment Parity for Nursing Home Care
COLUMBIA, Maryland, July 16 -- Post-Acute and Long-Term Care Medical Association issued the following news:
* * *
PALTmed Welcomes CMS Proposal to Restore Payment Parity for Nursing Home Care
Post-Acute and Long-Term Care Medical Association (PALTmed) welcomes the Centers for Medicare & Medicaid Services' (CMS) proposal in the CY 2027 Physician Fee Schedule proposed rule (CMS-1848-P) to restore practice expense parity for evaluation and management (E/M) visits in nursing facilities and skilled nursing facilities. The proposal would equalize payment for codes 99304-99316 across nursing home settings,
... Show Full Article
COLUMBIA, Maryland, July 16 -- Post-Acute and Long-Term Care Medical Association issued the following news:
* * *
PALTmed Welcomes CMS Proposal to Restore Payment Parity for Nursing Home Care
Post-Acute and Long-Term Care Medical Association (PALTmed) welcomes the Centers for Medicare & Medicaid Services' (CMS) proposal in the CY 2027 Physician Fee Schedule proposed rule (CMS-1848-P) to restore practice expense parity for evaluation and management (E/M) visits in nursing facilities and skilled nursing facilities. The proposal would equalize payment for codes 99304-99316 across nursing home settings,correcting a disparity that PALTmed has urged CMS to address since the CY 2026 practice expense redistribution took effect.
The existing payment differential has never reflected how care is actually delivered in nursing homes. The same clinician caring for the same resident in the same bed could be reimbursed at different rates simply because the resident's Medicare benefit status changed over the course of a few days.
Even more concerning, the lower payment applies to the patients who often require the most intensive care. Residents in a Medicare Part A stay are recovering from hospitalization, managing new or worsening medical conditions, and face the greatest risk of complications and avoidable hospitalization. Paying less for this level of care undervalues the complexity of the work and, over time, threatens access to clinicians in a specialty already challenged by workforce shortages.
"Every clinician who walks into a nursing facility brings the same training, clinical expertise, and practice expenses to the bedside, regardless of the residents in Medicare Part A status," said Leslie Eber, MD, CMD, FPALTC, president of PALTmed. "We appreciate that CMS listened to the concerns raised by PALTmed and our members, and we urge the agency to finalize this proposal. Nursing home residents are among Medicare's most medically complex patients, and they deserve access to clinicians who can continue providing the high-quality care they need."
PALTmed advocated for this change through formal comments, direct engagement with CMS, and grassroots efforts by members across the country who shared how the payment reduction affected their practices and the patients they serve. The association will submit comments supporting this proposal during the rule's public comment period and urges CMS to finalize this important correction.
* * *
About Post-Acute and Long-Term Care Medical Association (PALTmed)
Post-Acute and Long-Term Care Medical Association (PALTmed) is the only organization of its kind providing high-quality resources and education to the interdisciplinary team working in PALTC settings, including medical directors, attending physicians, nurse practitioners, physician associates, consultant pharmacists, and doctorly-prepared clinicians. PALTmed leads the way in empowering compassionate and skilled clinicians to deliver person-centered care in the post-acute and long-term care continuum.
Through its Certified Medical Director (CMD) credentialing program, PALTmed upholds excellence in medical leadership within PALTC. Committed to advancing high-quality, compassionate care, PALTmed fosters professional development, evidence-based clinical guidance, and advocacy to enhance outcomes for patients, residents, families, and healthcare teams.
* * *
Original text here: https://paltmed.org/news-media/paltmed-welcomes-cms-proposal-restore-payment-parity-nursing-home-care
[Category: Medical]
IDFA Expands Government Relations Team with New Director of PAC & Political Affairs
WASHINGTON, July 16 [Category: Food/Beverage] -- The International Dairy Foods Association issued the following news release:
* * *
IDFA Expands Government Relations Team with New Director of PAC & Political Affairs
New role builds on IDFA's growing federal and state advocacy capacity, grassroots network and political engagement strategy
-
The International Dairy Foods Association (IDFA) today announced that Elizabeth "Liz" Demorest has joined the organization as director of PAC & political affairs, further strengthening the association's advocacy and political engagement efforts on behalf
... Show Full Article
WASHINGTON, July 16 [Category: Food/Beverage] -- The International Dairy Foods Association issued the following news release:
* * *
IDFA Expands Government Relations Team with New Director of PAC & Political Affairs
New role builds on IDFA's growing federal and state advocacy capacity, grassroots network and political engagement strategy
-
The International Dairy Foods Association (IDFA) today announced that Elizabeth "Liz" Demorest has joined the organization as director of PAC & political affairs, further strengthening the association's advocacy and political engagement efforts on behalfof the U.S. dairy industry.
Demorest's appointment is the latest step in IDFA's broader effort to expand its advocacy capacity at the federal and state levels and grow the dairy industry's political footprint in Washington and across the country. Over the past year, IDFA has significantly grown its government relations team, expanded its state advocacy presence, launched its Rapid Response Advocates for Dairy (RRAD) grassroots network, and enhanced its political engagement strategy to deliver greater value to members and increase dairy's influence with policymakers.
In this role, Demorest will lead IDFA's PAC strategy and political engagement efforts, including PAC fundraising, donor engagement, compliance, member activation and political events. Reporting to Chelsie Keys, IDFA's senior vice president of government relations, Demorest will work closely with the government relations team to align political engagement with the association's federal and state advocacy priorities while creating more opportunities for members to build meaningful relationships with policymakers through congressional fly-ins, district meetings, political events, digital advocacy campaigns and other advocacy initiatives.
"Building a stronger, more impactful PAC is one of IDFA's highest advocacy priorities," said Michael Dykes, D.V.M., president and CEO of IDFA. "Liz's experience in political engagement and PAC management will help us expand dairy's political influence and strengthen relationships with policymakers. As IDFA works to ensure dairy has a more influential voice in Washington and in state capitals across the country, Liz's leadership will help our growing advocacy operation deliver greater value and stronger results for our members."
"Effective advocacy requires building strong, trusted relationships with policymakers," said Demorest. "I'm excited to join IDFA at a pivotal time as the association continues to strengthen its political engagement efforts and grow its PAC. I look forward to working with Chelsie, the IDFA government relations team, the Board and our members to strengthen dairy's voice in Washington and across the country."
Demorest brings more than 15 years of experience in PAC and grassroots advocacy management. Most recently, she served as Associate Director, Political Engagement at the American Academy of Dermatology Association, where she led the association's political action, grassroots and external affairs initiatives, oversaw PAC fundraising campaigns and managed the annual legislative fly-in. She previously held PAC and grassroots advocacy roles at the American College of Emergency Physicians, the National Association of Realtors and the American Congress of Obstetricians and Gynecologists.
Demorest earned a bachelor's degree in political science from Ohio University and holds a Certificate in PAC Management from the Public Affairs Council. She grew up on a cattle farm in Ohio and began her early career supporting agricultural events and local farmer membership through the Marion County Agricultural Society.
* * *
The International Dairy Foods Association (IDFA), Washington, D.C., represents the nation's dairy manufacturing and marketing industry, which supports more than 3 million jobs that generate $198 billion in wages and $779 billion in overall economic impact. IDFA's diverse membership ranges from multinational organizations to single-plant companies, from dairy companies and cooperatives to food retailers and suppliers, all on the cutting edge of innovation and sustainable business practices. Together, they represent most of the milk, cheese, ice cream, yogurt and cultured products, and dairy ingredients produced and marketed in the United States and sold throughout the world. Delicious, safe and nutritious, dairy foods offer unparalleled health and consumer benefits to people of all ages.
***
Original text here: https://www.idfa.org/news/idfa-expands-government-relations-team-with-new-director-of-pac-political-affairs
GSA's Ester Sztein Receives Prestigious American Geosciences Institute Award
PITTSBURGH, Pennsylvania, July 16 (TNSres) -- The Geological Society of America issued the following news release:
* * *
GSA's Ester Sztein Receives Prestigious American Geosciences Institute Award
Boulder, Colo., USA-The Geological Society of America (GSA) is pleased to announce that Ester Sztein, GSA's Director of International Programs, has been selected to receive the American Geosciences Institute's (AGI) Award for Outstanding Contribution to Public Understanding of the Geosciences.
This prestigious award is presented annually to an individual, organization, or institution whose work has
... Show Full Article
PITTSBURGH, Pennsylvania, July 16 (TNSres) -- The Geological Society of America issued the following news release:
* * *
GSA's Ester Sztein Receives Prestigious American Geosciences Institute Award
Boulder, Colo., USA-The Geological Society of America (GSA) is pleased to announce that Ester Sztein, GSA's Director of International Programs, has been selected to receive the American Geosciences Institute's (AGI) Award for Outstanding Contribution to Public Understanding of the Geosciences.
This prestigious award is presented annually to an individual, organization, or institution whose work hassignificantly advanced public appreciation and understanding of the geosciences and their importance to society. The award recognizes contributions that help people better understand the role geoscience plays in addressing economic, environmental, and societal challenges.
This recognition reflects Sztein's longstanding commitment to expanding access to geoscience education, fostering international collaboration, and connecting people around the world with the value and relevance of the earth sciences. Through her leadership, dedication, and advocacy, Sztein has helped strengthen the global geoscience community and increase public awareness of the critical role geoscientists play in understanding and addressing some of society's most pressing challenges.
Sztein's geosciences experience is significant, including more than 16 years at the National Academies of Science, Engineering, and Medicine (NASEM) where she served in a variety of roles, including Acting Director of the Board on International Scientific Organizations, where, among other activities, she managed the U.S. National Committees for four geoscience international scientific unions. In addition to her work at GSA, she also serves as the vice president for North America of the International Association for the Conservation of Geological Heritage (ProGEO.)
GSA's Interim Executive Director and CEO Bridgette Moore says, "We are proud to have Ester as a member of the GSA team and grateful for the impact she continues to make on our profession and our global community."
Sztein stated that she "is very honored to receive this important award, which recognizes the value of supporting and growing the U.S. and international geoscience community and its relationship with society."
The award will be presented at the Friends of AGI reception on Sunday, 11 October 2026, during GSA Connects 2026 in Denver, Colorado, USA.
* * *
About the Geological Society of America
The Geological Society of America (GSA) is a global professional society with more than 18,000 members across over 100 countries. As a leading voice for the geosciences, GSA advances the understanding of Earth's dynamic processes and fosters collaboration among scientists, educators, and policymakers. GSA publishes Geology, the top-ranked geoscience journal, along with a diverse portfolio of scholarly journals, books, and conference proceedings--several of which rank among Amazon's top 100 best-selling geology titles.
* * *
Original text here: https://www.geosociety.org/news/GSA's-ester-sztein-receives-prestigious-american-geosciences-institute-award
[Category: Science]
EPA Report to Congress Highlights Benefits of Diesel Emissions Reduction Act Program
FREDERICK, Maryland, July 16 (TNSrpt) -- The Engine Technology Forum issued the following news release:
* * *
New EPA Report to Congress Highlights Benefits of Diesel Emissions Reduction Act (DERA) Program
Results Support Reauthorization of DERA, H.R. 2140, Subject of Today's Energy and Commerce Hearing
-
WASHINGTON - The Diesel Emissions Reduction Act (DERA) is a valuable program that continues to deliver meaningful emissions reductions and fuel savings across the country as outlined in the U.S. Environmental Protection Agency's (EPA) Sixth Report to Congress (Report). Reauthorization of
... Show Full Article
FREDERICK, Maryland, July 16 (TNSrpt) -- The Engine Technology Forum issued the following news release:
* * *
New EPA Report to Congress Highlights Benefits of Diesel Emissions Reduction Act (DERA) Program
Results Support Reauthorization of DERA, H.R. 2140, Subject of Today's Energy and Commerce Hearing
-
WASHINGTON - The Diesel Emissions Reduction Act (DERA) is a valuable program that continues to deliver meaningful emissions reductions and fuel savings across the country as outlined in the U.S. Environmental Protection Agency's (EPA) Sixth Report to Congress (Report). Reauthorization ofDERA through H.R. 2140, which is being considered today by the House Energy and Commerce Committee's Environment Subcommittee, is strongly supported by the continued need for, and proven results of, the program outlined in the Report.
"DERA has been a bipartisan success story from the very beginning because of its structure and competitive process, successful implementation, ongoing need, and continued funding support. It's a program that has upgraded a wide range of technologies, from marine and locomotive engines, port drayage trucks, and school buses to fire trucks and industrial stationary generators in Tribal communities. We recognize and thank Reps. Matsui, Calvert, Pingree, and Langworthy for their unwavering leadership and support of H.R. 2140, the Diesel Emissions Reduction Act of 2025," said Allen Schaeffer, executive director of the Engine Technology Forum (ETF), based in Frederick, Md.
DERA provides funding assistance to accelerate the upgrade or retirement of older diesel engines, prioritizing projects that reduce emissions in nonattainment or maintenance areas for particulate matter (PM) and ozone. DERA competitive grant applications are evaluated based on how projects benefit areas with poor air quality and the extent to which they engage community stakeholders. The DERA program also prioritizes goods movement projects because these projects tend to take place in communities impacted by higher levels of diesel exhaust, such as those near ports, rail yards, and distribution centers.
Since the inception of DERA, funding requests have exceeded available funding in each fiscal year (FY). In FYs 2019 and 2020 alone, grant and rebate applicants requested $220 million more in funds than were available from DERA appropriations. This legislation - H.R. 2140 - reauthorizes the DERA program through 2029.
The DERA program promotes an array of diesel emissions reduction strategies by working with manufacturers, fleet operators, air quality professionals, environmental and community organizations, and Tribal, state, and local officials. Together, EPA and others work to achieve emissions reductions in areas experiencing diminished air quality from diesel fleets. DERA has separate national and state award programs.
According to the EPA report, more than 76,900 engines in vehicles, vessels, locomotives, and other pieces of equipment were replaced or retrofitted with DERA funds during FYs 2008 to 2020. DERA projects during these years are estimated to have reduced approximately 499,000 tons of nitrogen oxides (NOx) and 16,600 tons of PM over the lifetime of the replaced engines. These diesel emissions reduction projects are also estimated to have reduced approximately 19,400 tons of hydrocarbons (HC) and 66,600 tons of carbon monoxide (CO) and are expected to save over 572 million gallons of diesel fuel over the lifetime of the affected engines.
Approximately 58% of projects included school bus replacements. Additionally, there were more than 240 port and multi-sector projects, more than 90 municipal projects, and more than 90 construction projects. About 95% were diesel engines and vehicles. About 5% were natural gas, propane, gasoline, zero-emission, or hybrid engines and vehicles.
"EPA has consistently done an outstanding job administering this competitive program in a balanced and fair way, developing important tools that quantify emissions reductions, enhancing program efficiencies, and maximizing the use of available funds, all of which are outlined in the Report to Congress. Cost sharing and leveraging other funds enable the DERA program to consistently deliver a strong return on public investment," noted Schaeffer.
In FY 2019 and 2020:
* EPA estimates reductions of approximately 12,000 tons of NOx, 450 tons of PM2.5, 570 tons of HC, 1,680 tons of CO, and 33.5 million gallons of diesel fuel consumed over the lifetime of the engines and vehicles funded during FYs 2019 and 2020 through the DERA program.
* School buses were the most frequently funded replacements, with approximately 290 school buses retrofitted or replaced during FYs 2019 and 2020. Additionally, more than 40 replacements were port vehicles or engines, and approximately 30 were freight vehicles or engines.
* Approximately 70% of replacements were diesel engines and vehicles. Approximately 30% were natural gas, propane, gasoline, zero-emission, or hybrid engines and vehicles.
* Nearly 100 state projects were funded in FYs 2019 and 2020 to replace over 490 vehicles. The largest upgrade sector for the DERA state program during FYs 2019 and 2020 was school buses, which accounted for more than 240 vehicle replacements. Approximately 180 replacements were port marine vessels, nonroad vehicles, and on-road drayage trucks.
"As of December 2025, according to ETF's analysis of S&P Global Mobility TIPNet data, 67% of all commercial diesel vehicles (Class 3-8) on the road were 2010 and newer model year vehicles, which means that one-third are older models without the benefits of the most advanced emissions reduction technology," noted Schaeffer.
* * *
REPORT: https://www.epa.gov/system/files/documents/2026-06/420r26015.pdf
* * *
Original text here: https://enginetechforum.org/press-releases/posts/new-epa-report-to-congress-highlights-benefits-of-diesel-emissions-reduction-act-dera-program
[Category: Energy]
Chocolate Returns to No. 1 and Butter Pecan Surpasses Vanilla Ahead of National Ice Cream Day
WASHINGTON, July 16 [Category: Food/Beverage] -- The International Dairy Foods Association posted the following news release:
* * *
Chocolate Returns to No. 1 and Butter Pecan Surpasses Vanilla Ahead of National Ice Cream Day
*
IDFA survey finds cones, hot fudge and neighborhood ice cream trucks remain American favorites
WASHINGTON, July 16, 2026 -Chocolate has reclaimed the title of America's favorite ice cream flavor, while butter pecan has scooped past vanilla for second place, according to the International Dairy Foods Association's latest National Ice Cream & Frozen Novelty Trends Survey.
... Show Full Article
WASHINGTON, July 16 [Category: Food/Beverage] -- The International Dairy Foods Association posted the following news release:
* * *
Chocolate Returns to No. 1 and Butter Pecan Surpasses Vanilla Ahead of National Ice Cream Day
*
IDFA survey finds cones, hot fudge and neighborhood ice cream trucks remain American favorites
WASHINGTON, July 16, 2026 -Chocolate has reclaimed the title of America's favorite ice cream flavor, while butter pecan has scooped past vanilla for second place, according to the International Dairy Foods Association's latest National Ice Cream & Frozen Novelty Trends Survey.Ahead of National Ice Cream Day on Sunday, July 19, IDFA is serving up the latest findings on how Americans enjoy their favorite frozen treats.
Conducted in partnership with Morning Consult, the national survey collected responses from more than 2,200 U.S. adults on their favorite flavors, toppings, frozen novelties, ice cream traditions and more. The results confirm that ice cream remains one of America's most universally loved foods, with 97% of adults saying they love or like it.
Classic flavors continue to dominate, but American's preferences have shifted since IDFA's 2024 survey. Chocolate is back at No. 1 after vanilla claimed the top spot two years ago. Butter pecan has also risen above vanilla, while cookies and cream and caramel have joined the top five.
America's Top 5 Favorite Ice Cream Flavors in 2026:
1. Chocolate
2. Butter Pecan
3. Vanilla
4. Cookies and Cream/Oreo
5. Caramel/Salted Caramel
"Ice cream is America's favorite treat, and ice cream makers continue to earn that special place by creating products consumers cherish while constantly innovating to meet their changing tastes," said Michael Dykes, D.V.M., president and CEO of the International Dairy Foods Association. "From premium indulgence and creative new flavors to options with more protein and other attributes consumers are seeking, America's ice cream makers continue to expand what ice cream can be without losing the joy, nostalgia and great taste that make it so beloved."
That innovation also extends to the ingredients used to make America's favorite frozen treats. Through the voluntary IDFA Ice Cream Commitment, dozens of U.S. ice cream companies representing more than 90% of the ice cream sold nationwide have pledged to eliminate certified artificial colors from ice cream and frozen dairy desserts made with real milk and sold at food retail by the end of 2027. The commitment reflects the industry's continued work to respond to consumer preferences while preserving the taste, quality and variety ice cream lovers expect.
Here are a few more scoops from IDFA's National Ice Cream & Frozen Novelty Trends Survey:
Which frozen novelty is America's favorite?
* The classic ice cream cone is the clear winner, preferred by 40% of Americans.
* Ice cream sandwiches rank second at 24%, followed by mini-cups at 14% and ice cream bars at 11%.
Cone, bowl or straight from the carton?
* Waffle cones are America's favorite way to eat ice cream, selected by 30% of adults.
* Bowls rank second at 23%, followed by waffle bowls at 12% and sugar cones at 11%.
* Another 8% prefer to skip the dishes and eat their ice cream straight from the carton.
What toppings rise to the top?
* Hot fudge is America's favorite topping, selected by 31% of adults.
* Whipped cream follows at 27%, with caramel sauce at 21%, nuts at 19% and chocolate sauce at 18%.
* Granola, honey and cereal rank among Americans' least-selected toppings.
Are Americans ice cream lickers or biters?
* Nearly six in 10 Americans (59%) lick the ice cream first when eating a cone.
* Twenty-one percent bite directly into the ice cream, while 15% start by biting the top of the cone.
* A particularly daring 4% bite the bottom of the cone first.
Where do Americans prefer to enjoy ice cream?
* Home remains the favorite setting for 58% of adults.
* Twenty percent prefer visiting an ice cream shop, while 16% say ice cream is best enjoyed outdoors.
What is America's most iconic ice cream memory?
* Hearing the neighborhood ice cream truck ranks as the most "American" ice cream memory, selected by 29% of adults.
* Birthday party ice cream cake follows at 21%.
* Trips to the local scoop shop and sharing ice cream with a favorite family member each received 20%.
What matters most when choosing ice cream?
* Flavor is overwhelmingly the most important consideration, with 72% of adults calling it "very important."
* Price follows at 48%, while 39% say the size of the cone or container is very important.
The survey was conducted online by Morning Consult from April 7-9, 2026, among 2,205 U.S. adults. The results have a margin of error of +- 2 percentage points.
To explore the full findings, visit IDFA's National Ice Cream & Frozen Novelty Trends Survey page at IDFA.org.
Contact: press@idfa.org
The International Dairy Foods Association (IDFA), Washington, D.C., represents the nation's dairy manufacturing and marketing industry, which supports more than 3 million jobs that generate $198 billion in wages and $779 billion in overall economic impact. IDFA's diverse membership ranges from multinational organizations to single-plant companies, from dairy companies and cooperatives to food retailers and suppliers, all on the cutting edge of innovation and sustainable business practices. Together, they represent most of the milk, cheese, ice cream, yogurt and cultured products, and dairy ingredients produced and marketed in the United States and sold throughout the world. Delicious, safe and nutritious, dairy foods offer unparalleled health and consumer benefits to people of all ages.
***
Original text here: https://www.idfa.org/news/chocolate-returns-to-no-1-and-butter-pecan-surpasses-vanilla-ahead-of-national-ice-cream-day
Biosimilars Council and AAM Applauds House Introduction of the Expedited Access to Biosimilars Act
WASHINGTON, July 16 -- The Association for Accessible Medicines issued the following news release:
* * *
Biosimilars Council and AAM Applauds House Introduction of the Expedited Access to Biosimilars Act
Legislation codifies FDA's science-based approach to biosimilar review by limiting comparative efficacy studies
-
The Biosimilars Council and the Association for Accessible Medicines today applauded legislation, the Expedited Access to Biosimilars Act, introduced this week in the U.S. House of Representative by Congressman Nick Langworthy (NY-23) and Congresswoman Kim Schrier, M.D. (WA-08),
... Show Full Article
WASHINGTON, July 16 -- The Association for Accessible Medicines issued the following news release:
* * *
Biosimilars Council and AAM Applauds House Introduction of the Expedited Access to Biosimilars Act
Legislation codifies FDA's science-based approach to biosimilar review by limiting comparative efficacy studies
-
The Biosimilars Council and the Association for Accessible Medicines today applauded legislation, the Expedited Access to Biosimilars Act, introduced this week in the U.S. House of Representative by Congressman Nick Langworthy (NY-23) and Congresswoman Kim Schrier, M.D. (WA-08),to codify FDA's science-based approach to biosimilar review by limiting comparative efficacy studies. AAM and the Biosimilars Council have long advocated for a more efficient, science-based biosimilar development pathway that reduces unnecessary development costs and risks, encourages continued investment in biosimilars, and expands patient access to lower-cost medicines.
"Clinical efficacy studies are not the most effective way to provide the FDA with comparative data between biosimilars and their reference biologics when more robust and more effective analytical, functional, and pharmacokinetic methodologies can provide these data," said Alex Keeton, Executive Director of the Biosimilars Council.
The Biosimilars Council and AAM have long supported eliminating unnecessary comparative clinical efficacy studies. Doing so will reduce unnecessary development costs and risks while encouraging greater biosimilar competition. Clinical efficacy studies should be the exception rather than a generally applied rule and explain the limited circumstances in which they might be scientifically justified.
The Expedited Access to Biosimilars Act will codify FDA's guidance into law to ensure that the approval process is updated, safe, and predictable.
"Too often legacy regulations persist well beyond their usefulness," said John Murphy III, President and CEO of AAM. "Outdated and less effective clinical studies waste time, slow approvals, and ultimately cost American patients more money. We are greatly thankful to Representatives Langworthy and Schrier for their leadership on this issue and their focus on cutting costs for patients, and the FDA for their continued and persistent work on this issue."
* * *
About AAM
The Association for Accessible Medicines, your generics and biosimilars industry, is driven by the belief that access to safe, quality, effective medicine has a tremendous impact on a person's life and the world around them. AAM represents the manufacturers of finished generic pharmaceuticals and biosimilars, manufacturers of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals are 90 percent of prescriptions dispensed in the U.S. but only 12 percent of total drug spending.
* * *
About the Biosimilars Council
The Biosimilars Council, a division of the Association for Accessible Medicines, works to ensure a positive environment for patient access to biosimilar medicines. The Biosimilars Council is the leading source for information about the safety and efficacy of more affordable alternatives to costly brand biologic medicines. Areas of focus include public and health expert education, government affairs, legal affairs, and regulatory policy. More information is available at www.biosimilarscouncil.org.
* * *
Original text here: https://accessiblemeds.org/resources/press-releases/aam-applauds-house-introduction-expedited-access-biosimilars-act/
[Category: Pharmaceuticals]
American Lung Association Honors AstraZeneca with Outstanding Corporate Partner Award for 35 Years of Impact
WASHINGTON, July 16 [Category: Health Care] -- The American Lung Association posted the following news release:
* * *
American Lung Association Honors AstraZeneca with Outstanding Corporate Partner Award for 35 Years of Impact
*
On Friday, June 27, the American Lung Association honored AstraZeneca with the Outstanding Corporate Partner Award at its annual awards celebration in Chicago for their long-standing commitment, leadership and support of lung health. The 35-year partnership has been integral in supporting the Lung Association's work to save lives by improving lung health and preventing
... Show Full Article
WASHINGTON, July 16 [Category: Health Care] -- The American Lung Association posted the following news release:
* * *
American Lung Association Honors AstraZeneca with Outstanding Corporate Partner Award for 35 Years of Impact
*
On Friday, June 27, the American Lung Association honored AstraZeneca with the Outstanding Corporate Partner Award at its annual awards celebration in Chicago for their long-standing commitment, leadership and support of lung health. The 35-year partnership has been integral in supporting the Lung Association's work to save lives by improving lung health and preventinglung disease.
"We thank the entire AstraZeneca team for your incredible support over three decades. It is our relationship with industry, corporations, foundations and other peer organizations that enables the Lung Association to deliver life-changing and life-saving education, research and advocacy. These relationships are built on a foundation of leadership and a shared vision for a world free of lung disease," said Harold Wimmer, President and CEO of the American Lung Association. "We are proud to recognize AstraZeneca for its outstanding commitment to lung health and thank you for your active leadership in our Health Industry Council.
"We are deeply honored to receive the Outstanding Corporate Partner Award from the American Lung Association," said Dan Wygal, Vice President, US Corporate Affairs at AstraZeneca. "This recognition affirms our shared commitment to improving lung health and advancing science that benefits patients and communities everywhere. We look forward to strengthening this valuable partnership and continuing our joint efforts to reduce the burden of lung disease."
Over the past 35 years, AstraZeneca has invested over $8 million to further advance the Lung Association's critical mission. The partnership has educated people on lifesaving lung cancer screening, helped increase awareness about biomarker screening that vastly improves the lives of people living with lung cancer, helped people reduce asthma attacks and chronic obstructive pulmonary disease (COPD) exacerbations, supported work to advance policies that benefit patients with lung cancer and their families, and much more.
The Lung Association has partnered with AstraZeneca on critical education and awareness campaigns throughout the years. A few of the programs created through this partnership include:
* Lung Cancer Screening: For nearly four decades, AstraZeneca has consistently supported the Lung Association's work to educate people living in the U.S. about the vital importance of lung cancer screening at both the national and local community level. Thanks to AstraZeneca's unwavering commitment to defeat lung cancer, over the past five years, the survival rate for lung cancer has increased by 26% nationally to 29.7%.
* LungXperience partnership: As a part of the new LungXperience partnership, the Lung Association joined AstraZeneca and NASCAR to advance lung cancer screening, connecting people to direct, specialized care through the Lung Association's Lung Health Navigator program. So far, this program has referred 530 people to the Lung Health Navigator program, providing participants with one-to-one care from nurses and respiratory therapists to guide them in their screening journey.
* BEAT Lung Cancer Campaign: With shared values to defeat lung cancer, AstraZeneca has supported the Lung Association's United to BEAT Lung Cancer Campaign, dedicated to educating and building awareness for biomarker testing.
* Living Well With Asthma and COPD: AstraZeneca has steadfastly supported the Living Well With asthma and COPD launch and continuation of the Lung Health Navigator program not only for lung cancer but for COPD and asthma. AstraZeneca also continues to support Historically Black Colleges and Universities through Breathe Well Live Well initiatives.
* Advocacy Days: AstraZeneca has been a long-standing and vital supporter of the Lung Association's advocacy work. From their many-year commitment to supporting LUNG FORCE Advocacy Day to their willingness to support our new Respiratory Advocacy Day, their commitment to empowering patients and safeguarding lung health is unmatched.
Since 1904, the Lung Association has worked to champion lung health and pioneered the model of education, advocacy and research to support public health. In this work, the organization collaborates with partners and alliances that support efforts to defeat lung cancer, champion clean air for all, create a tobacco-free future and improve the quality of life for those with lung disease and their families. The Outstanding Corporate Partner Award recognizes these partners for their critical partnership in our mission.
***
Original text here: https://www.lung.org/media/press-releases/astrazeneca-corporate-partner-award-2026
